Trial · NCT03401229
Adverse events104
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 104
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Benra 30 mg | 37 | 207 | 57 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 43 | 203 | 54 |
| other | Viral upper respiratory tract infection | Infections and infestations | Benra 30 mg | 7 | 207 | 9 |
| other | Viral upper respiratory tract infection | Infections and infestations | Placebo | 14 | 203 | 15 |
| other | Headache | Nervous system disorders | Benra 30 mg | 7 | 207 | 9 |
| other | Headache | Nervous system disorders | Placebo | 16 | 203 | 18 |
| other | Asthma | Respiratory, thoracic and mediastinal disorders | Benra 30 mg | 21 | 207 | 30 |
| other | Asthma | Respiratory, thoracic and mediastinal disorders | Placebo | 30 | 203 | 54 |
| serious | Autoimmune haemolytic anaemia | Blood and lymphatic system disorders | Benra 30 mg | 1 | 207 | 1 |
| serious | Autoimmune haemolytic anaemia | Blood and lymphatic system disorders | Placebo | 0 | 203 | 0 |
| serious | Haemolytic uraemic syndrome | Blood and lymphatic system disorders | Benra 30 mg | 1 | 207 | 1 |
| serious | Haemolytic uraemic syndrome | Blood and lymphatic system disorders | Placebo | 0 | 203 | 0 |
| serious | Lymphadenopathy | Blood and lymphatic system disorders | Benra 30 mg | 0 | 207 | 0 |
| serious | Lymphadenopathy | Blood and lymphatic system disorders | Placebo | 1 | 203 | 1 |
| serious | Acute myocardial infarction | Cardiac disorders | Benra 30 mg | 1 | 207 | 1 |
| serious | Acute myocardial infarction | Cardiac disorders | Placebo | 0 | 203 | 0 |
| serious | Arrhythmia | Cardiac disorders | Benra 30 mg | 0 | 207 | 0 |
| serious | Arrhythmia | Cardiac disorders | Placebo | 1 | 203 | 1 |
| serious | Pericarditis | Cardiac disorders | Benra 30 mg | 2 | 207 | 3 |
| serious | Pericarditis | Cardiac disorders | Placebo | 0 | 203 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03401229/events